US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Psyence Biomedical Ltd

2.36

-2.6700-53.08%

Post-market: 3.971.61+68.22%19:59 EDT

Volume:2.48M

Turnover:9.09M

Market Cap:1.68M

PE:0.00

High:4.68

Open:4.50

Low:2.36

Close:5.03

Loading ...

Overview Company News Filings

Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?

Vertex Reports First Quarter 2025 Financial Results

North American Morning Briefing: Stock Futures Down As Oil Plunges

Is CVS Health Corporation (CVS) The Best Stock To Buy and Hold For 10 Years?

Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split

Centene Corporation (CNC): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential

Psychedelic: Clearmind completes clinical site initiations for AUD trial

Is UnitedHealth Group (UNH) the Best Large-Cap Value Stock to Buy as the Recession Hits?

Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

CVS Health vs. UnitedHealth: Which Healthcare Stock Has More Upside?

Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

CVS Health Takes the Lead in 2025 S&P 500 Chart: Is It a Buy Now?

Jim Cramer on CVS Health (CVS): “A Comeback Story with New Management!”

Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing

What Gives Elevance Health (ELV) an Attractive Opportunity in The Large Cap Space?

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Further Strengthens Scientific Advisory Board With Appointment of Dr. Dan J. Stein

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

UnitedHealth's Optum Rx & EPN Team Up for Fairer Pharmacy Payments

UnitedHealth Group (UNH): The Best Diabetes Stock to Buy According to Billionaires

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PBM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBM\",,,,,undefined,":{"symbol":"PBM","market":"US","secType":"STK","nameCN":"Psyence Biomedical Ltd","latestPrice":2.36,"timestamp":1754078400000,"preClose":5.03,"halted":0,"volume":2478737,"hourTrading":{"tag":"盘后","latestPrice":3.97,"preClose":2.36,"latestTime":"19:59 EDT","volume":1628548,"amount":6289018.7778,"timestamp":1754092799196},"delay":0,"floatShares":673600,"shares":713232,"eps":-612.9833,"marketStatus":"Market Closed","change":-2.67,"latestTime":"08-01 16:00:00 EDT","open":4.5,"high":4.6799,"low":2.36,"amount":9089362.0078736,"amplitude":0.461213,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-612.9833,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":5.03,"preHourTrading":{"tag":"盘前","latestPrice":4.46,"preClose":5.03,"latestTime":"09:27 EDT","volume":13730,"amount":60515.77134,"timestamp":1754054863779},"postHourTrading":{"tag":"盘后","latestPrice":3.97,"preClose":2.36,"latestTime":"19:59 EDT","volume":1628548,"amount":6289018.7778,"timestamp":1754092799196},"volumeRatio":0.3301070107110223},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBM\",,,,,undefined,":{"symbol":"PBM","floatShares":673600,"roa":"-54.20%","roe":"-457.86%","lyrEps":-4692.199211,"volumeRatio":0.3301070107110223,"shares":713232,"dividePrice":0,"high":4.6799,"amplitude":0.461213,"preClose":5.03,"low":2.36,"week52Low":2.36,"pbRate":"0.25","week52High":343.7062,"institutionHeld":0.0125,"latestPrice":2.36,"eps":-612.9833,"divideRate":0,"volume":2478737,"delay":0,"ttmEps":-612.9833,"open":4.5,"prevYearClose":16.8167,"prevWeekClose":11.5,"prevMonthClose":5.03,"prevQuarterClose":5.33,"fiveDayClose":11.5,"twentyDayClose":5.205,"sixtyDayClose":4.44},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533637668","title":"Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2533637668","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533637668?lang=en_us&edition=fundamental","pubTime":"2025-05-06 22:00","pubTimestamp":1746540000,"startTime":"0","endTime":"0","summary":"Lilly turned in strong first-quarter results, powered by its GLP-1 weight-loss drugs.But news about its Zepbound drug, along with lowered profit guidance, hurt the shares.The company's new oral GLP-1 drug, which avoids the use of injections, has huge potential.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/06/eli-lilly-stock-slips-on-outlook-is-it-time-to-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU2471134879.HKD","LU1093756325.SGD","LU0820561909.HKD","LU0672654240.SGD","BK4139","IE00BMG7P926.USD","LU1127390331.HKD","LU1232071149.USD","LU2361044865.SGD","LU0079474960.USD","LU2264538146.SGD","LU1988902786.USD","LU1280957306.USD","IE00BJJMRZ35.SGD","LU0198837287.USD","LU1868837136.USD","LU2461242641.AUD","SG9999015986.USD","IE00BMG7P694.USD","IE0004445239.USD","LU2237443895.HKD","LU1814569148.SGD","LU0266013472.USD","LU2491049909.HKD","PEG","BK4007","LU1069344957.HKD","SGXZ99366536.SGD","LU2552382215.SGD","LU1023059063.AUD","LU1093756168.USD","LU2237443978.SGD","LU1366192091.USD","SG9999018865.SGD","LU0689472784.USD","LLY","LU2237443622.USD","IE00BJT1NW94.SGD","LU1551013425.SGD","LU1868837300.USD","LU1057294990.SGD","LU0943347566.SGD","LU0096364046.USD","LU2750360997.AUD","LU0354030511.USD","PBM","SGXZ51526630.SGD","IE00BMG7P819.SGD","LU2471134796.USD"],"gpt_icon":1},{"id":"2533568415","title":"Vertex Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533568415","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533568415?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:01","pubTimestamp":1746475260,"startTime":"0","endTime":"0","summary":"— Total revenue of $2.77 billion, a 3% increase compared to Q1 2024; raised the low end of total revenue guidance by $100 million to a new range of $11.85 to $12 billion —。— Strong progress with CASGEVY, ALYFTREK and JOURNAVX launches —。— Povetacicept  IgAN Phase 3 interim analysis  cohort fully enrolled and zimislecel Phase 3 program to complete dosing this quarter, setting up potential filings in 2026; inaxaplin Phase 3 IA cohort on track to complete enrollment in the second half of 2025 —。— Four programs already in pivotal development, with pivotal study of pove in primary membranous nephropathy  to start this year —。Combined GAAP and Non-GAAP R&D, Acquired IPR&D and SG&A expenses were $1.4 billion and $1.2 billion, respectively, compared to $1.2 billion and $1.0 billion, respectively, in the first quarter of 2024. The increases were primarily due to continued R&D investment in support of multiple mid- and late-stage clinical development programs and increased commercial investment ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertex-reports-first-quarter-2025-200100412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF","IE00B19Z9Z06.USD","LU0289739699.SGD","IE0002270589.USD","BK4138","LU2456880835.USD","LU1815336091.USD","BK4093","BK4533","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2237438978.USD","LU2362541513.USD","BK4139","LU1093756168.USD","IE00B19Z3581.USD","LU2324357040.USD","LU0320765992.SGD","VERX","VTNR","BK4567","LU1035775433.USD","SG9999013999.USD","CHMP","LU1093756325.SGD","BK4588","BK4087","IE00B894F039.SGD","LU0234570918.USD","PBM","SCD","VRTX","UAE","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","SG9999001176.SGD","LU1430594728.SGD","LU0061475181.USD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","BK4532","BK4585","SG9999001176.USD","IE0002141913.USD","LU0889565916.HKD","LU1559883803.SGD","IE0009355771.USD","KSA"],"gpt_icon":0},{"id":"2533788302","title":"North American Morning Briefing: Stock Futures Down As Oil Plunges","url":"https://stock-news.laohu8.com/highlight/detail?id=2533788302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533788302?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:26","pubTimestamp":1746440760,"startTime":"0","endTime":"0","summary":"Stock futures were pointing to losses early on Monday after the S&P 500 notched its longest winning streak in more than 20 years last week.Trump on Sunday described the country as being in a transition period  and left open the possibility of an economic downturn.\"Anything can happen,\" he said when asked if a recession could happen.Oil prices slumped  after OPEC+ and its allies agreed to a larger output hike for a second straight month despite weak prices and an uncertain demand outlook.Investors will be looking toward Powell's remarks  on Wednesday, following a two-day meeting of the Fed's rate-setting committee.Berkshire Hathaway shares fell 2% premarket after Warren Buffett said he plans to step down  at year-end.Warner Bros. Discovery, Netflix, Walt Disney and Paramount  all fell nearly 3% after Trump's plans for 100% tariffs on foreign-made films weighed on shares.ISM Report on Business Services PMI for April; Earnings from Palantir Technologies, Ford Motor, Vertex Pharmaceuticals","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART","PBM","LU1914381329.SGD","HYMC","JBTM","BCRX","IE0034390439.USD","LU0234570918.USD","TRDA","US2Y.BOND","XGN","BRK.B","ET","LU0683600562.USD","ESCA","BK4567","BK4590","BK4561","AFG","LU0048573561.USD","US3Y.BOND","US7Y.BOND","HSIC","LU0130102774.USD","US30Y.BOND","BK4135","LU1074936037.SGD","LU0029874061.USD","CNA","JJSF","FRPT","US10Y.BOND","AXSM","US5Y.BOND","ENSV","US12M.BOND","ARES","IE0034235303.USD","CFBK","ALX","BK4539","LU0266013472.USD","LU1941712264.USD","FHTX","LU0203345920.USD","US6M.BOND","IE00BJLML261.HKD","AOMR","LU1571399168.USD","CMI"],"gpt_icon":1},{"id":"2533234945","title":"Is CVS Health Corporation (CVS) The Best Stock To Buy and Hold For 10 Years?","url":"https://stock-news.laohu8.com/highlight/detail?id=2533234945","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533234945?lang=en_us&edition=fundamental","pubTime":"2025-05-05 00:02","pubTimestamp":1746374521,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Stocks to Buy and Hold For 10 Years. In this article, we are going to take a look at where CVS Health Corporation  stands against the other stocks to buy and hold for 10 years.To compile our list of the 12 best stocks to buy and hold for 10 years, we looked for stocks with strong growth potential. We used search terms like “best stocks to buy and hold for 10 years” and reviewed financial media reports and various online resources to compile a list of more than 30 stocks that investors can consider buying and holding for the next decade. Next, we focused on the top 12 stocks most favored by institutional investors. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s Q4 2024 database of more than 1,000 elite hedge funds. Finally, the 12 best stocks to buy and hold for 10 years were ranked in ascending order based","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvs-health-corporation-cvs-best-160201344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0072461881.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","IE0002270589.USD","CVS","IE00B19Z3B42.SGD","BK4139","BK4550","IE00B19Z3581.USD","LU0211331839.USD","LU0070302665.USD","BK4504","LU1059921491.USD","BK4581","BK4588","PBM","LU0208291251.USD","LU1699723380.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU0061475181.USD","BK4196","LU0320765489.SGD","BK4585","LU0006061336.USD","LU0162691827.USD"],"gpt_icon":0},{"id":"2532066071","title":"Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2532066071","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532066071?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:30","pubTimestamp":1746099000,"startTime":"0","endTime":"0","summary":"New York, New York-- - Psyence Biomedical Ltd.   today announced the effective date of its 1-for-7.97 share consolidation  of the Company's issued and outstanding common shares. At a Special Meeting of Stockholders held on April 16, 2025, shareholders approved a share consolidation at a ratio of up to 1-for-50. Following this approval, the Company's Board of Directors authorized a 1-for-7.97 consolidation ratio, which will be implemented as the final share structure.The Company's common shares are expected to begin trading on a post-consolidated basis at the opening of the market on Monday, May 5, 2025. Following the consolidation, the Company's common shares will continue to trade under the symbol \"PBM\" on the Nasdaq Capital Market, with a new CUSIP number 74449F308.The consolidation is part of the Company's plan to regain compliance with the minimum bid price requirement of Nasdaq Listing Rule 5450  for continued listing on The Nasdaq Capital Market.Psyence BioMed aims to be one of t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psyence-biomed-announces-effective-date-113000789.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psyence-biomed-announces-effective-date-113000789.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","TQQQ","SQQQ","QLD","QID","NQmain","TSYW.SI","BK4139","PBM","NVIW.SI","PSQ","USJW.SI","PBMWW","MNQmain","USAW.SI"],"gpt_icon":1},{"id":"2532509290","title":"Centene Corporation (CNC): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2532509290","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532509290?lang=en_us&edition=fundamental","pubTime":"2025-04-30 23:43","pubTimestamp":1746027811,"startTime":"0","endTime":"0","summary":"We recently published a list of Billionaire Cliff Asness’ 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Centene Corporation  stands against other billionaire Cliff Asness’ stock picks with huge upside potential.Cliff Asness, the founder, managing principal, and chief investment officer ofAQR Capital Management, is a well-known figure in the world of finance. Starting with a $10 million commitment from a small group of investors in 1995, Asness was able to boost the Goldman Sachs Global Alpha Fund’s assets to more than $100 million in just a handful of months. Cliff Asness’ investment strategies, which focus on value and momentum, have delivered exceptional returns for AQR, setting him apart from his fellow hedge fund managers. As a testament, the fund has produced positive returns over the last three years, with its greatest year in 2022, when it returned 43.5%.A sovereign wealth fund for the U.S., which President Trump has also begun ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/centene-corporation-cnc-among-billionaire-154331168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1291159041.SGD","LU0130518102.USD","PBM","CNC","BK4154","IE0034235188.USD","LU0130517989.USD","BK4594","LU2362540622.SGD","LU2362541273.HKD","BK4139","LU0130103400.USD","LU0648001328.SGD","LU1989771016.USD","LU0477156797.USD","LU1201861165.SGD","BK4588","LU0648000940.SGD","LU0130102774.USD","LU1699723380.USD","LU1201861249.SGD","BK4585","LU0980610538.SGD","BK4601","LU0477156953.USD","LU2362541513.USD"],"gpt_icon":1},{"id":"2530215933","title":"Psychedelic: Clearmind completes clinical site initiations for AUD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530215933","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530215933?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:30","pubTimestamp":1745595026,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing completion and clinical site partnerships.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.“AUD remains one of the most urgent and underserved public health challenges globally,” said Dr. Adi Zuloff-Shani, CEO. “With millions affected and current treatments often falling short, the study initiation for our FDA-approved CMND-100 trial marks a critical step toward potentially transforming the treatment landscape for alcoholism. We are honored to collaborate with world renowned institutions such as Yale and Johns Hopkins as we advance our mission to potentially provide safe, effective, and innovative solutions for individuals those suffering from alcoholism.”“Completing dosing of all participants in Part A of our 005 tria","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SEEL","ATAI","ENTBF","BK4007","CMND","KTTA","SNPX","DRUG","AGNPF","CYBN","GHRS","PBM","RLMD","SPRC","RVVTF","BK4168","BETRF","MDXXF","MYCOF","SILO","BK4539","BK4547","BK4139","QNTM","PHRRF","CMPS","PSYGF","NUMIF","NRXP","FLHLF","MNMD","MIRA","ENVB","ALID","IXHL","BK4202","OPTHF"],"gpt_icon":0},{"id":"2528012284","title":"Is UnitedHealth Group (UNH) the Best Large-Cap Value Stock to Buy as the Recession Hits?","url":"https://stock-news.laohu8.com/highlight/detail?id=2528012284","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528012284?lang=en_us&edition=fundamental","pubTime":"2025-04-19 05:15","pubTimestamp":1745010917,"startTime":"0","endTime":"0","summary":"We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where UnitedHealth Group Incorporated stands against other best large-cap value stocks to buy as the recession hits.Goldman Sachs highlighted that equities around the world traded in and out of a bear market — which is often defined as a 20% decline from the recent peak. According to Peter Oppenheimer, chief global equity strategist at Goldman Sachs Research, the history of bear markets can provide some clues regarding the duration and severity of such downturns. U.S. stocks ended significantly higher after Trump announced his decision to put a 90-day pause on the additional country-specific portion of the reciprocal tariffs. That being said, Oppenheimer believes that a sustained rebound isn’t yet in place. As per the strategist, the valuations are required to adjust further before equities can shift into the “hope” phase of the next cycle.To list","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/unitedhealth-group-unh-best-large-211517241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1791710582.SGD","LU2237443549.SGD","LU0965509101.SGD","SGXZ81514606.USD","IE00BFTCPJ56.SGD","UNH","LU1037948897.HKD","PBM","IE00B1BXHZ80.USD","LU0354030438.USD","LU2242649171.HKD","LU2468319806.SGD","SG9999001176.SGD","LU1934455194.USD","IE00B2B36J28.USD","LU1778281490.HKD","LU1934455863.HKD","LU0417517546.SGD","IE0002141913.USD","LU0708995401.HKD","LU0052756011.USD","LU1674673691.USD","LU1791807156.HKD","LU0316494557.USD","LU0234572021.USD","SG9999018865.SGD","LU0310799852.SGD","IE00BZ1G4Q59.USD","SGXZ57979304.SGD","IE00BFSS8Q28.SGD","LU1868836591.USD","LU2361044949.HKD","LU2552382132.HKD","BK4532","LU2125154778.USD","LU0795875086.SGD","LU2361044865.SGD","LU0345770308.USD","BK4550","SGXZ31699556.SGD","LU0158827781.USD","LU0820561818.USD","IE00B19Z3581.USD","LU0077335932.USD","IE00BJJMRZ35.SGD","LU1267930730.SGD","LU1868836914.USD","BK4516","LU2279689827.SGD","LU0029864427.USD"],"gpt_icon":1},{"id":"2528377728","title":"Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2528377728","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528377728?lang=en_us&edition=fundamental","pubTime":"2025-04-18 07:17","pubTimestamp":1744931820,"startTime":"0","endTime":"0","summary":"New York, New York-- - Psyence Biomedical Ltd.   announced today that it received a notification letter dated April 16, 2025, from the Listings Qualifications Department  of the Nasdaq Stock Market LLC  indicating that the Company is not in compliance with Nasdaq Listing Rule 5550, which requires listed securities to maintain a minimum bid price of $1.00 per share . The Staff's determination is based on the closing bid price of the Company's common shares being below $1.00 for 30 consecutive business days from March 5, 2025 through April 15, 2025.The Company intends to appeal this determination and request a hearing before a Nasdaq Hearings Panel. Under Nasdaq rules, this request will stay the suspension of trading and the delisting of the Company's securities pending the outcome of the hearing and any extension the Hearings Panel provides.Psyence BioMed is one of the few multi-asset, vertically integrated biopharmaceutical companies specializing in psychedelic-based therapeutics. It i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psyence-biomed-receives-nasdaq-notification-231700357.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psyence-biomed-receives-nasdaq-notification-231700357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","LU1165135440.EUR","BK4585","PBMWW","LU0347712357.USD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","LU1721428933.USD","LU2210149790.SGD","MNQmain","TSYW.SI","BK4139","LU1543694498.USD","LU2210150020.SGD","USAW.SI","NDAQ","LU2413666699.HKD","PSQ","LU2413666426.HKD","BK4121","IE00BN0W2V16.EUR","LU2041044095.USD","IE00BKPKM429.USD","NQmain","IE00BGHQF748.EUR","LU2092937221.SGD","NVIW.SI","LU2095319765.USD","BK4588","LU2229751404.USD","QLD","TQQQ","IE00B64PRP62.GBP","BK4567",".IXIC","SQQQ","A","BK4112","LU2089279066.USD","PBM","QID"],"gpt_icon":1},{"id":"2527783584","title":"CVS Health vs. UnitedHealth: Which Healthcare Stock Has More Upside?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527783584","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527783584?lang=en_us&edition=fundamental","pubTime":"2025-04-16 03:00","pubTimestamp":1744743600,"startTime":"0","endTime":"0","summary":"Currently, CVS Health CVS and UnitedHealth Group UNH are two major vertically integrated behemoths in the U.S. healthcare market and key constituents of the S&P 500 index. Both companies have transformed beyond their original identities — CVS Health from a retail pharmacy chain into a healthcare powerhouse through its acquisition of Aetna and UnitedHealth from a traditional insurer into a tech-enabled care provider via its expansive Optum platform. Each now combines insurance, care delivery, pharmacy benefit management  and value-based service models to offer end-to-end healthcare solutions.For investors, it is difficult to choose between the two, as both CVS and UnitedHealth continue to diversify their revenue streams and scale up their clinical and digital infrastructure. While they share structural similarities in business segmentation — insurance, health services, and pharmacy operations — their financial trajectories, operating margins, capital deployment strategies and risk expos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvs-health-vs-unitedhealth-healthcare-190000788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z3B42.SGD","LU0072461881.USD","LU1119994496.HKD","LU1934455863.HKD","LU1983299246.USD","IE000M9KFDE8.USD","LU1066051498.USD","LU0211326839.USD","IE00BZ9MQY76.HKD","LU1066051811.HKD","LU0820562030.AUD","SG9999018857.SGD","IE0004445015.USD","LU1791710400.SGD","PBM","BK4581","LU0316494557.USD","LU0912757837.SGD","HCSG","UNH","LU0708995401.HKD","LU0128525689.USD","LU0353189680.USD","LU0211326755.USD","CVS","LU0820561909.HKD","LU0158827948.USD","LU0097036916.USD","LU0238689110.USD","LU1066053197.SGD","LU1914381329.SGD","SG9999014898.SGD","SGXZ57979304.SGD","LU2361045086.USD","LU2023251221.USD","BK4533","LU0882574055.USD","LU2264538146.SGD","LU1496350502.SGD","LU0417517546.SGD","IE00BZ1G4Q59.USD","MCR","LU0545039389.USD","IE00BJT1NW94.SGD","IE0005OL40V9.USD","LU0029864427.USD","LU1261432733.SGD","LU1720051108.HKD","LU0310799852.SGD","LU1084165304.USD"],"gpt_icon":1},{"id":"2527416319","title":"Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2527416319","media":"Newsfile","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527416319?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:30","pubTimestamp":1744720200,"startTime":"0","endTime":"0","summary":"New York, New York-- - Psyence Biomedical Ltd.   today announced a strategic follow-on investment of USD $500,000 into PsyLabs, a privately-held company specializing in the production of psychedelic active pharmaceutical ingredients  and extracts for research, clinical trials, and drug development. This follow-on investment underscores Psyence BioMed's commitment to building a vertically integrated, multi-asset psychedelics biotech platform with robust supply chain security and clinical development capabilities.This new capital investment builds on the exclusive, royalty-bearing IP licensing agreement formalized between the two companies in September 2024, following an initial investment where Psyence BioMed acquired an 11.13% equity stake in PsyLabs. Under the terms of that agreement, PsyLabs supplies Psyence BioMed with pharmaceutical-grade, EU-GMP, nature-derived  psilocybin for use in future clinical trials and eventual commercialization in substance use disorders .Tony Budden, Chi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psyence-biomed-announces-usd-500-123000986.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psyence-biomed-announces-usd-500-123000986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4535","USD","BK4139","BK4551","BK4023","PBM","API","BK4503","PBMWW"],"gpt_icon":0},{"id":"2525899338","title":"Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2525899338","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525899338?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:00","pubTimestamp":1744113600,"startTime":"0","endTime":"0","summary":"New partnership strengthens Psyence BioMed's global clinical trial capabilities, accelerating the development of psilocybin-assisted therapy for adjustment disorder. New York, New York-- - Psyence BioMed   today announced the signing of a Letter of Intent  with Southern Star Research Pty Ltd, a premier Australian contract research organization . This collaboration will accelerate Psyence BioMed's ongoing Phase IIb psilocybin clinical trial in Australia, which focuses on adjustment disorder in patients diagnosed with cancer.Adjustment disorder ranks as the seventh most frequently diagnosed psychiatric condition globally, affecting millions of people who currently have no FDA-approved pharmaceutical treatment.Psyence BioMed senior leadership will discuss the new agreement during the Company's corporate webinar on Thursday, April 10, 2025, at 12:00 PM EST.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psyence-biomed-signs-loi-southern-120000514.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psyence-biomed-signs-loi-southern-120000514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU0320765646.SGD","IE00BMG7P587.USD","LU1929549753.HKD","IE00BMG7P819.SGD","IE00BMG7P926.USD","LU1162221912.USD","LU2133065610.SGD","LU1718418525.SGD","BK4588","PBMWW","LU0310799852.SGD","LU1621767810.EUR","IE00B29SXL02.USD","LU0211328371.USD","LU1621768115.EUR","LU1267930490.SGD","IE00B29SXK94.USD","LU1621768206.USD","PBM","BK4081","IE00BMG7P694.USD","LU2384288077.EUR","LU0211327993.USD","BK4585","SO","LU1621767737.EUR"],"gpt_icon":0},{"id":"2525767690","title":"CVS Health Takes the Lead in 2025 S&P 500 Chart: Is It a Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2525767690","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525767690?lang=en_us&edition=fundamental","pubTime":"2025-04-08 03:00","pubTimestamp":1744052400,"startTime":"0","endTime":"0","summary":"In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health CVS has emerged as an unexpected outperformer. After a rough 2024, marked by high utilization at its Aetna insurance unit as well as reimbursement pressure, CVS Health has experienced a dramatic recovery so far in 2025. The stock has become the S&P 500’s top performer, with a year-to-date return exceeding 41%, thereby outperforming all other index members by a significant margin.This PBM and pharmacy retail powerhouse has also outperformed its major competitors — Herbalife Ltd. HLF and Walgreens Boots WBA, which registered growth of 23.6% and 14.6%, respectively, during this period.CVS Health is optimistic regarding its path forward in 2025 and beyond, which involves strengthening its positioning in Medicare Advantage. Management is confident about 2025 pricing, which is based on prudent assumptions for utilization trends. It expects these actions to drive a 100- to 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvs-health-takes-lead-2025-190000258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZL793.SGD","IE00BZ1G4Q59.USD","PBM","BK4581","LU0061475181.USD","SSO","LU0823414478.USD","IE00B19Z3B42.SGD","OEF","IVV","IE00B19Z3581.USD","GTLS",".SPX","IE00BKVL7J92.USD","LU0320765489.SGD","LU1699723380.USD","VOO","LU0321505868.SGD","LU0006061336.USD","LU2211815571.USD","SPY","LU0162691827.USD","LU0208291251.USD","LU1571399168.USD","WBA","BK4534","BK4550","IE0002270589.USD","SDS","LU0211331839.USD","ESmain","IE00B19Z4B17.USD","BK4128","SH","CVS","LU2249611893.SGD","LU2264538146.SGD","LU1059921491.USD","LU0072461881.USD","HLF","OEX","BK4161","BK4504","BK4183","BK4588","BK4532","BK4196","LU1064131342.USD"],"gpt_icon":1},{"id":"2523929927","title":"Jim Cramer on CVS Health (CVS): “A Comeback Story with New Management!”","url":"https://stock-news.laohu8.com/highlight/detail?id=2523929927","media":"Insider Monkey","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523929927?lang=en_us&edition=fundamental","pubTime":"2025-03-31 23:13","pubTimestamp":1743434027,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where CVS Health Corporation’s  stands against other stocks that Jim Cramer looked at recently.Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on Thursday as he challenged the prevailing pessimism among some on Wall Street. He highlighted the diverse range of sectors showing gains.READ ALSOJim Cramer Put These 16 Stocks Under a MicroscopeandJim Cramer Commented on These 8 Stocks Recently. Cramer observed that when investors are focused on long-standing winners, like tech stocks, it can be easy to miss when their dominance starts to wane. Cramer expressed his hesitation to part ways with tech given its long-term success but he pointed out something surprising as he reviewed the top-performing sectors.Why are we interested in the stocks that hedge funds pile into?The reason is simple: our research has shown that we can outperfor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jim-cramer-cvs-health-cvs-151347661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4227","LU0823434583.USD","LU0170899867.USD","LU1267930730.SGD","LU0345769631.USD","LU0353189763.USD","LU2361044949.HKD","LU0070302665.USD","LU0061474705.USD","LU0127658192.USD","LU0557290698.USD","LU0238689110.USD","LU2543165471.USD","LU1366192091.USD","IE00BQXX3D17.EUR","LU2361045086.USD","LU0109391861.USD","LU2461242641.AUD","BK4527","LU0823434740.USD","LU0345769128.USD","IE0004086264.USD","LU0276348264.USD","GB00BDT5M118.USD","LU0889565833.HKD","SGXZ99366536.SGD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU2106854487.HKD","BK4581","LU1571399168.USD","LU0345770993.USD","PBM","LU0056508442.USD","MA","BK4196","LU2764262908.HKD","LU0640476718.USD","IE00BKVL7J92.USD","LU0868494617.USD","LU2417539215.USD","LU2361044865.SGD","IE00BHPRN162.USD","IE00B1XK9C88.USD","IE00BFSS8Q28.SGD","LU0390134368.USD","CVS","LU1119994496.HKD","LU1852331112.SGD","LU0096362180.USD"],"gpt_icon":1},{"id":"2523794994","title":"Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2523794994","media":"Newsfile","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523794994?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422400,"startTime":"0","endTime":"0","summary":"Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025. New York, New York-- - Psyence Biomedical Ltd.   releases the following update:. At Psyence BioMed, we are truly grateful for the ongoing support and trust of our shareholders. Your dedication to our vision drives our growth, and we're excited to share our latest global achievements. We are committed to keeping you well-informed and engaged. As we embrace the exciting opportunities in the psychedelics industry, we look forward to continuing this conversation together.Our exclusive royalty-bearing IP licensing agreement with Psyence UK Group Ltd. , an international psychedelic Active Pharmaceutical Ingredient  development company with a facility that is federally licensed to cultivate and export psychedelic compounds to the legal medical and research markets, may support long-term access to EU-GMP certified ingredients. This partnership strengthens our position in the growing psy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/corporate-psyence-biomedical-ltd-redefines-120000215.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corporate-psyence-biomedical-ltd-redefines-120000215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PBM","STRK","BK4585","BK4503","PBMWW","BK4516","BK4596","BK4595","API","BK4588","BK4535","BK4551","BK4023","BK4600"],"gpt_icon":1},{"id":"2522957488","title":"What Gives Elevance Health (ELV) an Attractive Opportunity in The Large Cap Space?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522957488","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522957488?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:57","pubTimestamp":1743166645,"startTime":"0","endTime":"0","summary":"River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, AMG River Road Large Cap Value Select Fund returned 0.43% compared to  return for the Russell 1000 Value Index. For the year 2024, the fund returned 24.59% significantly outperforming Index return of 14.37%. Stocks rallied in November after a Republican victory but declined sharply following hawkish Fed comments. Shorter duration stocks, including small caps and value, lost most of their post-election gains by the end of December. For more information on the fund’s best picks in 2024, please check its top five holdings.River Road Large Cap Value Select Fund stated the following regarding Elevance Health, Inc.  in its Q4 2024 investor letter:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gives-elevance-health-elv-attractive-125725904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2244417387.USD","ELV","BK4588","LU0068578508.USD","LU0061474960.USD","SG9999011175.SGD","LU1815333072.USD","LU0187121727.USD","LU0208291251.USD","LU0640476718.USD","SGXZ23171101.USD","SG9999001077.SGD","LU2430703178.SGD","LU0882574055.USD","LU1983299246.USD","SG9999004303.SGD","LU1023059063.AUD","BK4139","LU0006306889.USD","LU1506573853.SGD","LU0114720955.EUR","LU2357305700.SGD","LU0070302665.USD","LU0211331839.USD","LU1057294990.SGD","LU1720051108.HKD","LU0048573561.USD","LU1548497426.USD","LU0251131958.USD","LU0985489474.SGD","LU0122379950.USD","LU0557290698.USD","LU1280957306.USD","LU1670627923.USD","LU2362541513.USD","PBM","LU2362540622.SGD","LU2505996681.GBP","LU0320765489.SGD","BK4154","LU1489326972.SGD","LU2237957902.USD","LU2430703251.USD","LU0433182093.SGD","LU0266013472.USD","LU2108987350.USD","LU0878866978.SGD","LU0058720904.USD","LU0225283273.USD","LU1670628061.USD"],"gpt_icon":0},{"id":"2522006189","title":"Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Further Strengthens Scientific Advisory Board With Appointment of Dr. Dan J. Stein","url":"https://stock-news.laohu8.com/highlight/detail?id=2522006189","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522006189?lang=en_us&edition=fundamental","pubTime":"2025-03-25 22:47","pubTimestamp":1742914020,"startTime":"0","endTime":"0","summary":"According to a news release issued by PBM, Dr. Stein is the Professor and Chair of the Dept of Psychiatry and Mental Health at the University of Cape Town  and Director of the South African Medical Research Council  Unit on Risk & Resilience in Mental Disorders. Dr. Stein will work closely with SAB chairman, Albert P. Garcia-Romeu, Ph.D, an Associate Professor in the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine. The PBM news release goes on to state that in addition to the continuation of PBM's Phase IIb clinical trial of psilocybin as a potential treatment for Adjustment Disorder in Palliative Care, PBM will also be advancing plans for its second development indication in Alcohol Use Disorder, introducing an entirely new class of psilocybin-based therapeutics to address significant unmet needs in mental health and addiction.To register for the corporate webinar, please access the following link: Psyence Biomed Corporate Webinar. Informe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psyence-groups-nasdaq-listed-associate-144700681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBMWW","NVIW.SI","IE00BGHQF748.EUR","NDAQ","PSQ","MRC","BK4588","PBM","BK4585","MNQmain",".IXIC","BK4104","LU2095319765.USD","QLD","BK4139","LU2210150020.SGD","IE00BKPKM429.USD","LU2210149790.SGD","QID","TSYW.SI","BK4112","SQQQ","USAW.SI","NQmain","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","USJW.SI","TQQQ"],"gpt_icon":1},{"id":"2521172612","title":"Psychedelic: Exclusive talk with biotech company Clearmind Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2521172612","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521172612?lang=en_us&edition=fundamental","pubTime":"2025-03-22 22:30","pubTimestamp":1742653811,"startTime":"0","endTime":"0","summary":"In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Mark Haden, vice president of business development at Clearmind Medicine , a psychedelic pharmaceutical biotech company focused on development of therapeutics to solve underserved health problems. Here are some highlights:. Discover stocks' market position with detailed  competitor analyses.“Think of this space as being two overlapping circles, a Venn diagram,” Haden said. “There are addiction treatments, like counseling, Alcoholics Anonymous and some pharmaceutical interventions like Antabuse, naltrexone and acamprosate. I ran an addictions treatment program for 28 years and I can assure you that there is relatively low efficacy, the dropout rate is high, and the treatments tend to be very long-term. That’s the first circle.”“You can take MEAI if you are addicted to alcohol and you don’t want to stop,” Haden said. “You can add MEAI to your alcohol and we believe it will result in people drinking less. It c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KTTA","SEEL","AGNPF","ENTBF","MNMD","PSYGF","CMPS","RLMD","BETRF","OPTHF","RVVTF","SILO","CYBN","SNPX","BK4202","BK4547","BK4539","MDXXF","BK4139","GHRS","PBM","BK4168","MIRA","CMND","QNTM","ATAI","ALID","BK4007","DRUG","IXHL","PHRRF","FLHLF","NRXP","SPRC","MYCOF","NUMIF"],"gpt_icon":0},{"id":"2521613253","title":"UnitedHealth's Optum Rx & EPN Team Up for Fairer Pharmacy Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2521613253","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521613253?lang=en_us&edition=fundamental","pubTime":"2025-03-22 00:55","pubTimestamp":1742576100,"startTime":"0","endTime":"0","summary":"UnitedHealth Group’s UNH Optum Rx recently announced a major step toward modernizing pharmacy payments, a decision that could strengthen its market position and financial outlook. By adopting a cost-based reimbursement model, Optum Rx aims to provide fairer payments to pharmacies while improving medication access and affordability for consumers. Epic Pharmacy Network has partnered with Optum Rx to implement this model.This shift is especially beneficial for independent and community pharmacies, which have long struggled with rising drug prices and unpredictable reimbursement rates. With over 24,000 independent pharmacies in its network, Optum Rx’s new model ensures financial stability for these businesses, helping them maintain better medication stocks and improve patient care.This move bodes well for UNH as it is expected to increase pharmacy participation in Optum Rx’s network, enhancing service delivery and consumer satisfaction. By eliminating retroactive payment adjustments and re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/unitedhealths-optum-rx-epn-team-165500343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0456855351.SGD","SG9999017495.SGD","ENSG","LU1854103824.USD","IE00B2B36J28.USD","IE00B4JS1V06.HKD","LU1267930573.SGD","LU2461242641.AUD","LU1037948541.HKD","SG9999002224.SGD","LU1732800096.USD","LU1064131342.USD","BK4585","LU2125154778.USD","LU2491050154.USD","LU0823416689.USD","LU0965509283.SGD","LU0011850046.USD","UNH","LU2211815571.USD","LU0965509101.SGD","LU1084165304.USD","MD","PBM","IE00B894F039.SGD","SGXZ81514606.USD","TISI","LU0708994859.HKD","LU0661504455.SGD","SGXZ51526630.SGD","ADUS","LU0238689110.USD","LU1323610961.USD","IE00B19Z3B42.SGD","LU2244417387.USD","LU1674673691.USD","IE00B19Z8X17.USD","BK4588","LU0114720955.EUR","LU0965508806.USD","IE0004445015.USD","IE00B19Z8W00.USD","LU0128525929.USD","LU1989771016.USD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU0029864427.USD","LU2552382058.USD","LU1066051811.HKD","LU0949170772.SGD"],"gpt_icon":0},{"id":"2520870879","title":"UnitedHealth Group (UNH): The Best Diabetes Stock to Buy According to Billionaires","url":"https://stock-news.laohu8.com/highlight/detail?id=2520870879","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520870879?lang=en_us&edition=fundamental","pubTime":"2025-03-19 01:36","pubTimestamp":1742319384,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where UnitedHealth Group Incorporated  stands against other best diabetes stocks to buy according to billionaires.The Growing Market and Innovation in Continuous Glucose Monitoring  Technology. The GlobalData marketed products database shows that there are currently 97 products in the CGM category. Most of these devices are standard CGMs, with only a few being implanted sensors. 133 products are either approved or in the development stage, according to the GlobalData pipeline products database. The research indicates that this market niche is expanding quickly and is a hub for innovative new technologies like implantable CGMs.Twelve percent of adult Americans report having taken a GLP-1 drug at some point, according to the most recent KFF Health Tracking poll. In the previous fi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/unitedhealth-group-unh-best-diabetes-173624813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","UNH","LU0187121727.USD","BK4154","LU0094547139.USD","LU0342679015.USD","LU0545039389.USD","LU1983299246.USD","LU1061106388.HKD","LU0345770308.USD","LU0320765059.SGD","IE00B19Z8X17.USD","LU0528227936.USD","LU2087625088.SGD","SGXZ31699556.SGD","LU0496365809.HKD","LU0097036916.USD","LU0689472784.USD","LU2360032135.SGD","CAGR","LU2264538146.SGD","LU2552382058.USD","LU0353189680.USD","LU2242649171.HKD","LU0289739699.SGD","LU0345770993.USD","LU0128525929.USD","SG9999002224.SGD","LU0965509101.SGD","LU1720051108.HKD","LU0820561909.HKD","LU2552382132.HKD","LU0708995401.HKD","LU0661504455.SGD","PBM","BK4532","LU0557290698.USD","LU1064131342.USD","LU1057294990.SGD","LU0976567544.SGD","LU0198837287.USD","LU0211326839.USD","LU0107464264.USD","LU2111349929.HKD","LU0912757837.SGD","BK4585","LU1291159041.SGD","LU0354030511.USD","IE00B1XK9C88.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":60,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"PBM","defaultRemindTime":1746451800000,"type":"split","dateTimestamp":1746417600000,"forFactor":797,"toFactor":100,"ratio":7.97},{"market":"US","date":"2024-11-26","symbol":"PBM","defaultRemindTime":1732631400000,"type":"split","dateTimestamp":1732597200000,"forFactor":75,"toFactor":1,"ratio":75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBM","date":"2025-08-01","current":2.899625,"percent":0.935657,"low":-8.987173,"twenty":-2.443883,"median":-0.117823,"eighty":-0.042564,"high":43.62106,"avg":0.434374,"sd":6.867289,"marketCap":2933812},"quantilePoints":[{"date":"2024-02-09","current":-4.032357,"twenty":-6.238869,"median":-6.072412,"eighty":-4.789887,"marketCap":12687649},{"date":"2024-02-16","current":-2.839339,"twenty":-6.098548,"median":-3.798256,"eighty":-3.119893,"marketCap":8908805},{"date":"2024-02-23","current":-2.317077,"twenty":-5.416526,"median":-3.308726,"eighty":-2.830575,"marketCap":7275145},{"date":"2024-03-01","current":-2.358335,"twenty":-4.411122,"median":-2.857169,"eighty":-2.443954,"marketCap":7364862},{"date":"2024-03-08","current":-5.40272,"twenty":-4.595223,"median":-2.890292,"eighty":-2.448252,"marketCap":17006136},{"date":"2024-03-15","current":-6.789855,"twenty":-5.670597,"median":-3.448439,"eighty":-2.49853,"marketCap":21291147},{"date":"2024-03-22","current":-4.959176,"twenty":-5.522615,"median":-3.851628,"eighty":-2.531651,"marketCap":15533164},{"date":"2024-03-28","current":-5.045126,"twenty":-5.473209,"median":-4.390178,"eighty":-2.58397,"marketCap":15800977},{"date":"2024-04-05","current":-4.43423,"twenty":-5.384879,"median":-4.562142,"eighty":-2.723572,"marketCap":13926285},{"date":"2024-04-12","current":-3.616183,"twenty":-5.308825,"median":-4.386712,"eighty":-2.826193,"marketCap":11169148},{"date":"2024-04-19","current":-2.969424,"twenty":-5.158983,"median":-4.227564,"eighty":-2.846471,"marketCap":9153854},{"date":"2024-04-26","current":-3.634228,"twenty":-5.044947,"median":-3.989124,"eighty":-2.883667,"marketCap":11244136},{"date":"2024-05-03","current":-5.498334,"twenty":-5.135216,"median":-4.022166,"eighty":-2.931227,"marketCap":17006136},{"date":"2024-05-10","current":-4.755664,"twenty":-5.044947,"median":-4.198236,"eighty":-2.950931,"marketCap":14729724},{"date":"2024-05-17","current":-3.914422,"twenty":-5.029183,"median":-4.161003,"eighty":-2.965515,"marketCap":12185499},{"date":"2024-05-24","current":-3.576034,"twenty":-4.995271,"median":-3.989124,"eighty":-2.992841,"marketCap":11063362},{"date":"2024-05-31","current":-2.410174,"twenty":-4.97525,"median":-3.912167,"eighty":-2.927321,"marketCap":10042674},{"date":"2024-06-07","current":-2.153089,"twenty":-4.945403,"median":-3.739796,"eighty":-2.692286,"marketCap":8971456},{"date":"2024-06-14","current":-1.939708,"twenty":-4.890182,"median":-3.700097,"eighty":-2.466859,"marketCap":8082344},{"date":"2024-06-21","current":-1.253291,"twenty":-4.889663,"median":-3.668675,"eighty":-2.422386,"marketCap":5222190},{"date":"2024-06-28","current":-0.96407,"twenty":-4.844987,"median":-3.634228,"eighty":-2.361971,"marketCap":4017069},{"date":"2024-07-05","current":-0.935148,"twenty":-4.815866,"median":-3.576034,"eighty":-2.32332,"marketCap":3896557},{"date":"2024-07-12","current":-0.998455,"twenty":-4.766248,"median":-3.491099,"eighty":-2.088818,"marketCap":4160345},{"date":"2024-07-19","current":-1.323989,"twenty":-4.726555,"median":-3.448439,"eighty":-1.937394,"marketCap":5516775},{"date":"2024-07-26","current":-1.867403,"twenty":-4.683035,"median":-3.197485,"eighty":-1.910851,"marketCap":7781064},{"date":"2024-08-02","current":-0.143956,"twenty":-4.658595,"median":-2.969424,"eighty":-1.31949,"marketCap":7364628},{"date":"2024-08-09","current":-0.138564,"twenty":-4.597134,"median":-2.93318,"eighty":-1.252648,"marketCap":7088789},{"date":"2024-08-16","current":-0.175224,"twenty":-4.56626,"median":-2.839339,"eighty":-1.14223,"marketCap":8964295},{"date":"2024-08-23","current":-0.164846,"twenty":-4.484876,"median":-2.620747,"eighty":-1.025128,"marketCap":8433350},{"date":"2024-08-30","current":-0.133743,"twenty":-4.446042,"median":-2.530201,"eighty":-0.96664,"marketCap":6842183},{"date":"2024-09-06","current":-0.062172,"twenty":-4.437003,"median":-2.444094,"eighty":-0.946331,"marketCap":3180663},{"date":"2024-09-13","current":-0.050913,"twenty":-4.377208,"median":-2.41628,"eighty":-0.171823,"marketCap":2604637},{"date":"2024-09-20","current":-0.039131,"twenty":-4.329259,"median":-2.362614,"eighty":-0.163756,"marketCap":2001897},{"date":"2024-09-27","current":-0.035312,"twenty":-4.305444,"median":-2.355493,"eighty":-0.148457,"marketCap":1806550},{"date":"2024-10-04","current":-0.032669,"twenty":-4.254131,"median":-2.317077,"eighty":-0.14305,"marketCap":1671309},{"date":"2024-10-11","current":-0.031494,"twenty":-4.19237,"median":-2.120953,"eighty":-0.135288,"marketCap":1611202},{"date":"2024-10-18","current":-0.035247,"twenty":-4.164165,"median":-2.088818,"eighty":-0.127633,"marketCap":1803210},{"date":"2024-10-25","current":-0.031592,"twenty":-4.083815,"median":-1.933924,"eighty":-0.075611,"marketCap":1616211},{"date":"2024-11-01","current":-0.02265,"twenty":-4.026242,"median":-1.927818,"eighty":-0.057485,"marketCap":1158729},{"date":"2024-11-08","current":-0.024869,"twenty":-3.982516,"median":-1.638758,"eighty":-0.044294,"marketCap":1272265},{"date":"2024-11-15","current":-0.049784,"twenty":-3.931086,"median":-1.323989,"eighty":-0.044294,"marketCap":2546883},{"date":"2024-11-22","current":-0.042798,"twenty":-3.911717,"median":-1.256183,"eighty":-0.044338,"marketCap":2189514},{"date":"2024-11-29","current":-0.045389,"twenty":-3.854339,"median":-1.251684,"eighty":-0.044435,"marketCap":2322054},{"date":"2024-12-06","current":-0.046144,"twenty":-3.758505,"median":-1.181949,"eighty":-0.045374,"marketCap":2360678},{"date":"2024-12-13","current":-0.036019,"twenty":-3.736446,"median":-1.098558,"eighty":-0.042081,"marketCap":1842723},{"date":"2024-12-20","current":-0.213027,"twenty":-3.720507,"median":-1.025128,"eighty":-0.041056,"marketCap":10898254},{"date":"2024-12-27","current":-0.195572,"twenty":-3.702521,"median":-0.998455,"eighty":-0.041494,"marketCap":10005291},{"date":"2025-01-03","current":-0.174804,"twenty":-3.696057,"median":-0.967283,"eighty":-0.041676,"marketCap":8942782},{"date":"2025-01-10","current":-0.147112,"twenty":-3.67593,"median":-0.957643,"eighty":-0.042486,"marketCap":7526104},{"date":"2025-01-17","current":-0.1549,"twenty":-3.667341,"median":-0.574087,"eighty":-0.042776,"marketCap":7924545},{"date":"2025-01-24","current":-0.172934,"twenty":-3.665023,"median":-0.208553,"eighty":-0.043408,"marketCap":8057358},{"date":"2025-01-31","current":-0.14918,"twenty":-3.646165,"median":-0.184323,"eighty":-0.044744,"marketCap":6950578},{"date":"2025-02-07","current":-0.129701,"twenty":-3.623401,"median":-0.178377,"eighty":-0.045379,"marketCap":6043019},{"date":"2025-02-14","current":-0.132551,"twenty":-3.592094,"median":-0.174804,"eighty":-0.045783,"marketCap":6175832},{"date":"2025-02-21","current":-0.123525,"twenty":-3.571282,"median":-0.172934,"eighty":-0.046085,"marketCap":5755256},{"date":"2025-02-28","current":-0.117823,"twenty":-3.543472,"median":-0.170272,"eighty":-0.046183,"marketCap":5489629},{"date":"2025-03-07","current":-0.087417,"twenty":-3.495369,"median":-0.16615,"eighty":-0.046596,"marketCap":4072950},{"date":"2025-03-14","current":-0.074485,"twenty":-3.463351,"median":-0.163664,"eighty":-0.047435,"marketCap":3470419},{"date":"2025-03-21","current":-0.059349,"twenty":-3.451625,"median":-0.159632,"eighty":-0.048363,"marketCap":2765179},{"date":"2025-03-28","current":-0.05971,"twenty":-3.386977,"median":-0.158361,"eighty":-0.049116,"marketCap":2782002},{"date":"2025-04-04","current":-0.04489,"twenty":-3.267253,"median":-0.1549,"eighty":-0.049116,"marketCap":2091532},{"date":"2025-04-11","current":-0.043618,"twenty":-3.203179,"median":-0.154152,"eighty":-0.046323,"marketCap":2032227},{"date":"2025-04-17","current":-0.042568,"twenty":-3.140804,"median":-0.151236,"eighty":-0.046065,"marketCap":1983334},{"date":"2025-04-25","current":-0.053422,"twenty":-3.016258,"median":-0.148843,"eighty":-0.045369,"marketCap":2489014},{"date":"2025-05-02","current":-0.04217,"twenty":-2.968121,"median":-0.146958,"eighty":-0.044944,"marketCap":1964773},{"date":"2025-05-09","current":-0.047195,"twenty":-2.958916,"median":-0.143956,"eighty":-0.045202,"marketCap":2198901},{"date":"2025-05-16","current":-0.065096,"twenty":-2.939039,"median":-0.143033,"eighty":-0.045369,"marketCap":3032967},{"date":"2025-05-23","current":-0.055332,"twenty":-2.910166,"median":-0.139192,"eighty":-0.045482,"marketCap":2578022},{"date":"2025-05-30","current":-0.065345,"twenty":-2.857169,"median":-0.138564,"eighty":-0.045852,"marketCap":3044574},{"date":"2025-06-06","current":-0.063844,"twenty":-2.839339,"median":-0.135018,"eighty":-0.046045,"marketCap":2974641},{"date":"2025-06-13","current":-0.058023,"twenty":-2.817429,"median":-0.132806,"eighty":-0.046068,"marketCap":2703424},{"date":"2025-06-20","current":-0.061591,"twenty":-2.692286,"median":-0.131126,"eighty":-0.046129,"marketCap":2869653},{"date":"2025-06-27","current":26.979573,"twenty":-2.596595,"median":-0.130176,"eighty":-0.046129,"marketCap":27297662},{"date":"2025-07-03","current":27.487604,"twenty":-2.551768,"median":-0.129464,"eighty":-0.045667,"marketCap":27811683},{"date":"2025-07-11","current":26.19376,"twenty":-2.531167,"median":-0.127325,"eighty":-0.04489,"marketCap":26502584},{"date":"2025-07-18","current":27.61963,"twenty":-2.482695,"median":-0.125116,"eighty":-0.043883,"marketCap":27945265},{"date":"2025-07-25","current":5.7589,"twenty":-2.446866,"median":-0.121624,"eighty":-0.042776,"marketCap":5826797},{"date":"2025-08-01","current":2.899625,"twenty":-2.443883,"median":-0.117823,"eighty":-0.042564,"marketCap":2933812}],"updateTime":1754212862907}}}